Is microscopic hematuria of bladder cancer usually an early stage?

The symptom of bladder cancer is intermittent painless gross hematuria. Early hematuria usually lasts for 1 to 2 days, or about a week. Even without treatment, it will improve or disappear on its own. The time is uncertain. After a period of time, painless gross hematuria will reappear. The interval is uncertain, which may be one month or several months. It is easy for patients to delay treatment by thinking that their condition has improved or cured. This is mainly because the early tumor is relatively small, and there will be small areas of bleeding, mucosal ulceration and other problems. The blood will enter the bladder and mix with the urine, and finally hematuria will occur. However, hematuria caused by bladder cancer will not cause pain, tingling or burning, and is mostly painless. Microscopic hematuria means that the degree of hematuria is relatively mild.

Is chemotherapy necessary after complete bladder resection?

The GC regimen is recommended as the first-line regimen for intravenous systemic chemotherapy of bladder cancer. The specific drugs include gemcitabine and cisplatin. There are two options for single-cycle administration: 21 days and 28 days. If the patient receives postoperative intravenous chemotherapy, 6 cycles are recommended. Bladder cancer is a malignant tumor of the urinary system with a high degree of malignancy. Generally, patients after bladder cancer surgery need further chemotherapy. If the pathological examination results indicate the presence of high-risk recurrence factors, chemotherapy will be needed later to reduce the risk of recurrence and metastasis.

What are the recurrence factors of bladder cancer?

What are the reasons for the easy recurrence of bladder cancer? Bladder cancer is a relatively serious malignant tumor disease. Many patients will have recurrences even after timely treatment. The main reasons for the recurrence of this disease are central growth, special environment and immune deficiency. After understanding these reasons, patients must not be careless after treatment. They must be checked regularly so that they can be discovered and treated in time after recurrence. Defects of surgical methods: For superficial bladder cancer, whether it is open surgery or transurethral resection (TUR), it may cause tumor residues or surgical implants due to unclear identification or unfamiliar operation, leading to early recurrence. As we all know, cancer is a disease that is difficult to cure, and the same is true for bladder cancer.